Robert Alter, MD
Advertisement
Robert Alter, MD, practices in Hackensack and North Bergen, NJ, and specializes in medical oncology and hematology. Alter, who has been treating patients in the New Jersey community for more than 15 years and is the chairman of the Transfusion Committee at St. Clare’s Hospital, is involved in genitourinary and head and neck cancer research.
Articles by Robert Alter, MD
Robert Alter, MD, of John Theurer Cancer Center, describes the rationale for treating a 58-year-old male with advanced renal cell carcinoma with the combination of lenvatinib and everolimus following progression on first-line therapy.
Advertisement
Latest Updated Articles
Risk Stratification of Patients With Advanced RCCSeptember 22nd 2020
- Second-Line Treatment Options for Advanced RCC
September 22nd 2020
- Advanced RCC Treatment Selection
September 22nd 2020
- Novel Therapies in Advanced RCC
September 22nd 2020
- Case Overview: 58-Year-Old Man With Advanced RCC
September 22nd 2020
- Lenvatinib and Everolimus for Advanced RCC
September 22nd 2020
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Panel Votes 10-3 In Favor of RP1 Plus Nivolumab for Advanced Melanoma
2
Improving Survival, Quality of Life, and Cost-Effectiveness for Allo-HCT
3
FDA Grants Priority Review to Subcutaneous Amivantamab for Advanced HNSCC
4
NCCN Lists Gedatolisib Regimens as Preferred Option in HR+/HER2– Metastatic Breast Cancer
5